Trinity Biotech plc (TRIB) Stock Analysis

Trinity Biotech plc (TRIB) is a publicly traded company in the HEALTHCARE sector. It trades at $0.73, carries a market capitalization of $14.56M. This page summarizes the public market data, fundamentals, and frequently asked questions for TRIB, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

Market Sentiment

Trinity Biotech plc currently has a Neutral sentiment score of 0.03.

About Trinity Biotech plc

Trinity Biotech plc is a distinguished player in the medical diagnostics industry, focusing on the development, manufacturing, and marketing of innovative diagnostic products for clinical laboratories and point-of-care applications. With a strong global footprint across the United States, Africa, Asia, and Europe, the company is strategically positioned to meet the increasing demand for reliable and rapid diagnostic solutions. Headquartered in Bray, Ireland, Trinity Biotech is committed to ex...

GNG Research Analysis

GNG Research scores Trinity Biotech plc (TRIB) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for TRIB.

Frequently Asked Questions

Does TRIB pay dividends?

Trinity Biotech plc (TRIB) does not currently pay a regular dividend.

What is TRIB's market cap?

Trinity Biotech plc (TRIB) has a market capitalization of $14.56M with a current stock price of $0.73.